MedlinePlus Medical Encyclopedia: Primary myelofibrosis

Skip navigation


Medical Encyclopedia
Other encyclopedia topics:	A-Ag Ah-Ap Aq-Az B-Bk Bl-Bz C-Cg Ch-Co Cp-Cz D-Di Dj-Dz E-Ep Eq-Ez F G H-Hf Hg-Hz I-In Io-Iz J K L-Ln Lo-Lz M-Mf Mg-Mz N O P-Pl Pm-Pz Q R S-Sh Si-Sp Sq-Sz T-Tn To-Tz U V W X Y Z 0-9

Primary myelofibrosis

Contents of this page:
Alternative Names Definition Causes Symptoms Exams and Tests Treatment	Outlook (Prognosis) Possible Complications When to Contact a Medical Professional Prevention References

Alternative Names

Myelofibrosis; Idiopathic myelofibrosis; Myeloid metaplasia; Agnogenic myeloid metaplasia

Definition Return to top

Primary myelofibrosis is a disorder of the bone marrow, in which the marrow is replaced by fibrous (scar) tissue.

Causes Return to top

The cause of primary myelofibrosis is unknown. Scarring of the bone marrow causes blood to form in abnormal sites, such as the liver and spleen. This causes swelling of these organs.

There are no known risk factors.

The disorder usually develops slowly in people over age 50.

Symptoms Return to top

Abdominal fullness related to an enlarged spleen
Bone pain
Bruising
Easy bleeding
Fatigue
Increased susceptibility to infection
Pallor
Shortness of breath while doing physical work

Exams and Tests Return to top

Physical examination shows spleen swelling. Later in the disease, it may also show an enlarged liver.

Tests that may be done include:

CBC (complete blood count)
Platelet count

An examination of the blood shows teardrop-shaped red blood cells. Bone marrow biopsy may be done to rule out other causes of the symptoms.

Treatment Return to top

There is no specific treatment for primary myelofibrosis. The goal of treatment is to relieve symptoms. Treatment may involve:

Blood transfusions to correct anemia
Radiation and chemotherapy
Medicines called recombinant erythropoietin or androgens to help stimulate red blood cell production
Splenectomy (removal of the spleen) if swelling causes symptoms

In young people, bone marrow transplants appear to improve the outlook.

Outlook (Prognosis) Return to top

This disorder causes slowly worsening bone marrow failure with severe anemia. Low platelet count leads to easy bleeding, and spleen swelling may slowly get worse.

The average survival of people with primary myelofibrosis is about 5 years. However, many people survive for decades.

Possible Complications Return to top

Acute myelogenous leukemia
Liver failure

When to Contact a Medical Professional Return to top

Call for an appointment with your health care provider if symptoms of this disorder develop. Uncontrolled bleeding, shortness of breath, jaundice, and confusion that gets worse require urgent or emergency care.

Prevention Return to top

There is no known prevention.

References Return to top

Hoffman R, Benz Jr. EJ, Shattil SJ, et al. Hematology: Basic Principles and Practice. 4th ed. Philladelphia, Pa: Churchill Livingston; 2005.

McPherson RA and Pincus MR. Henry's Clinical Diagnosis and Management by Laboratory Methods. 21st ed. Philadelphia, Pa: WB Saunders; 2007:561-62.

Update Date: 7/11/2008

Updated by: David C. Dugdale, III, MD, Professor of Medicine, Division of General Medicine, Department of Medicine, University of Washington School of Medicine; and James R. Mason, MD, Oncologist, Director, Blood and Marrow Transplantation Program and Stem Cell Processing Lab, Scripps Clinic, Torrey Pines, California. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2009, A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.